Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R. Baer, Richard A. Larson, Stephen L. George et al.|Blood|2002Cited by 366
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance ModulatorMisbah Qadir, Maria R. Baer, Kieran L. O’Loughlin et al.|Clinical Cancer Research|2005Cited by 239
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance ProteinHans Minderman, Maria R. Baer, Kieran L. O’Loughlin et al.|Clinical Cancer Research|2004Cited by 169
Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.Tracy A. Brooks, Hans Minderman, Kieran L. O’Loughlin et al.|PubMed|2003Cited by 118
Flow cytometric analysis of breast cancer resistance protein expression and functionHans Minderman, Maria R. Baer, Attaya Suvannasankha et al.|Cytometry|2002Cited by 86